Lixisenatide shows efficacy in type 2 diabetes management

04/5/2012 | Medscape (free registration)

A higher proportion of drug-naive type 2 diabetes patients achieved blood glucose levels lower than 7% with once-daily lixisenatide for 12 weeks compared with those who received placebo treatment, researchers reported in Diabetes Care. Lixisenatide-treated patients also had bigger drops in two-hour postprandial glucose levels than those in the placebo group, researchers noted.

View Full Article in:

Medscape (free registration)

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Director, Corporate Counsel - Regulatory Law
Regeneron
Tarrytown, NY
ISHN - Chief Compliance Officer
Mountain States Health Alliance
Johnson City, TN
Active Implantable Medical Device (AIMD) Product Expert
BSI
Nationwide, SL_Nationwide
Finance Manager - ENT
Medtronic
Jacksonville, FL
Consumer Directed Health Plan (CDH) Product Offering Manager
Blue Cross Blue Shield MA
Quincy, MA